Suppression of intracellular calcium levels and inhibition of degranulation in RBL-2H3 mast cells by the sesquiterpene lactone parthenolide.

Pretreatment with parthenolide for 60 min inhibited the antigen-induced degranulation of RBL-2H3 mast cells; the IC(50) value being 4.5 ± 0.4 µM. The inhibition was not due to suppression of the phosphatidylinositol 3-kinase pathway because the antigen-induced phosphorylation of Akt was not inhibited by parthenolide. The antigen-induced increase in intracellular calcium levels was prevented by parthenolide, suggesting that parthenolide inhibited the antigen-induced degranulation by suppressing an increase in intracellular calcium levels. In support of this, parthenolide was found to prevent ionomycin-induced degranulation by inhibiting an increase in intracellular calcium levels. Therefore, parthenolide inhibits the degranulation of mast cells by preventing an increase in intracellular calcium levels.

[1]  B. Xiao,et al.  Increase in cytosolic calcium maintains plasma membrane integrity through the formation of microtubule ring structure in apoptotic cervical cancer cells induced by trichosanthin , 2009, Cell biology international.

[2]  T. Seyama,et al.  Suppression of the antigen-stimulated RBL-2H3 mast cell activation by Artekeiskeanol A. , 2009, Planta medica.

[3]  N. Nonomura,et al.  Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder overactivity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-kappaB phosphorylation. , 2009, The Journal of urology.

[4]  D. Endo,et al.  Inhibitory effects of parthenolide on antigen-induced microtubule formation and degranulation in mast cells. , 2008, International immunopharmacology.

[5]  S. Bischoff.  Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data , 2007, Nature Reviews Immunology.

[6]  J. E. Warnick,et al.  Anti-inflammatory and anti-hyperalgesic effects of sesquiterpene lactones from Magnolia and Bear's foot , 2004, Pharmacology Biochemistry and Behavior.

[7]  B. Fiebich,et al.  Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells , 2002, Journal of Neuroimmunology.

[8]  J. Blanco,et al.  Nuclear Factor- (cid:1) B Inhibitors as Potential Novel Anti-Inflammatory Agents for the Treatment of Immune Glomerulonephritis , 2002 .

[9]  H. Uchi,et al.  The sesquiterpene lactone parthenolide inhibits LPS- but not TNF-alpha-induced maturation of human monocyte-derived dendritic cells by inhibition of the p38 mitogen-activated protein kinase pathway. , 2002, The Journal of allergy and clinical immunology.

[10]  M. Moskowitz,et al.  Nuclear factor‐κB as a molecular target for migraine therapy , 2002 .

[11]  H. Wong,et al.  Sesquiterpene Lactone Parthenolide, an Inhibitor of I&kgr;B Kinase Complex and Nuclear Factor-&kgr;B, Exerts Beneficial Effects in Myocardial Reperfusion Injury , 2002, Shock.

[12]  A. Hsu,et al.  Phosphoinositide 3-Kinase Facilitates Antigen-stimulated Ca2+ Influx in RBL-2H3 Mast Cells via a Phosphatidylinositol 3,4,5-Trisphosphate-sensitive Ca2+Entry Mechanism* , 2001, The Journal of Biological Chemistry.

[13]  A. Hsu,et al.  Phosphoinositide 3-kinase facilitates antigen-stimulated Ca(2+) influx in RBL-2H3 mast cells via a phosphatidylinositol 3,4,5-trisphosphate-sensitive Ca(2+) entry mechanism. , 2001, The Journal of biological chemistry.

[14]  S. Kulkarni,et al.  Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. , 1999, Journal of ethnopharmacology.

[15]  T. Hofmann,et al.  The Antiinflammatory Sesquiterpene Lactone Parthenolide Inhibits NF-κB by Targeting the IκB Kinase Complex , 1999, The Journal of Immunology.

[16]  G. Schinella,et al.  Effect of the Chloroform Extract of Tanacetum vulgare and one of its Active Principles, Parthenolide, on Experimental Gastric Ulcer in Rats , 1999, The Journal of pharmacy and pharmacology.

[17]  M. Recio,et al.  Anti‐inflammatory Effects of South American Tanacetum vulgare , 1998, The Journal of pharmacy and pharmacology.